贝康医疗(02170.HK)胚胎处理液获国家药监局批准

阿斯达克财经
Aug 26, 2025

贝康医疗(02170.HK) 公布,旗下VitBase胚胎处理液(Gems培养液)已于近日正式获得国家药监局签发注册证,标志着国产高端培养液正式迈入国际领先阵营,打破逾三十年的进口品牌垄断局面。VitBase隶属于贝康旗下国际品牌BMX所开发的明星产品GEMS系列,该培养液早前已通过Cook Medical在华注册推广,预期将布助于中国辅助生殖行业摆脱进口依赖,实现供应链自主可控,并大幅降低治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10